256 related articles for article (PubMed ID: 20228225)
1. CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.
Lo BK; Yu M; Zloty D; Cowan B; Shapiro J; McElwee KJ
Am J Pathol; 2010 May; 176(5):2435-46. PubMed ID: 20228225
[TBL] [Abstract][Full Text] [Related]
2. CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes.
Lo BK; Jalili RB; Zloty D; Ghahary A; Cowan B; Dutz JP; Carr N; Shapiro J; McElwee KJ
Br J Dermatol; 2011 Nov; 165(5):1030-6. PubMed ID: 21711334
[TBL] [Abstract][Full Text] [Related]
3. Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytes.
Chung BM; Arutyunov A; Ilagan E; Yao N; Wills-Karp M; Coulombe PA
J Cell Biol; 2015 Mar; 208(5):613-27. PubMed ID: 25713416
[TBL] [Abstract][Full Text] [Related]
4. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
Trotta T; Costantini S; Colonna G
Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Chemokine Receptor CXCR3 and its Ligand CXCL 11 in Basal Cell Carcinoma.
Ansari MK; Gupta P; Singh A; Ramesh V; Siraj F
Indian Dermatol Online J; 2023; 14(2):232-236. PubMed ID: 37089859
[TBL] [Abstract][Full Text] [Related]
6. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
7. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studies.
Palladino P; Portella L; Colonna G; Raucci R; Saviano G; Rossi F; Napolitano M; Scala S; Castello G; Costantini S
Chem Biol Drug Des; 2012 Aug; 80(2):254-65. PubMed ID: 22531000
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
13. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
14. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
15. Optic neuritis: chemokine receptor CXCR3 and its ligands.
Sørensen TL; Roed H; Sellebjerg F
Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
[TBL] [Abstract][Full Text] [Related]
16. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
17. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
18. Study on the relationship between CXCR3 and its ligands and tubal tuberculosis.
Sun H; Fan J; Shang X; Tuohetaerbaike B; Li Y; Lv J; Wang Y; Wang L; Wang J; Ma X
Life Sci; 2021 May; 272():119047. PubMed ID: 33454369
[TBL] [Abstract][Full Text] [Related]
19. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
20. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
